The global mycoplasma diagnostics devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of mycoplasma infections and the rising demand for rapid and accurate diagnosis.
PCR-based diagnostic devices are expected to dominate the global mycoplasma diagnostics devices market during the forecast period, owing to their high accuracy and specificity in detecting mycoplasmas. Immunoassay-based diagnostic devices are also expected to witness significant growth due to their ease of use and low cost. DNA staining-based diagnostic devices are also anticipated to grow significantly due to their ability in detecting multiple species at once, which helps in reducing time required for diagnosis as well as costs incurred by healthcare providers.
- The increasing prevalence of chronic respiratory diseases such as asthma and COPD is expected to drive the demand for Mycoplasma Diagnostics Devices.
- The increasing number of patients with chronic respiratory diseases is expected to drive the demand for Mycoplasma Diagnostics Devices.
- The growing awareness about the importance of diagnosing mycoplasma infections in patients with chronic respiratory diseases is expected to drive the demand for Mycoplasma Diagnostics Devices.
- Increasing research and development activities by key players in this market are also driving growth.
- Increasing government funding on research and development activities related to mycoplasmosis are also driving growth.
Industry Growth Insights published a new data on “Mycoplasma Diagnostics Devices Market”. The research report is titled “Mycoplasma Diagnostics Devices Market research by Types (PCR, Immunoassay, DNA Staining, Microbial Culture Techniques, Other), By Applications (Hospitals, Clinics, Diagnostic Laboratories, Other), By Players/Companies Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Holding, Savyon Diagnostics, Tecan Group, Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycoplasma Diagnostics Devices Market Research Report
By Type
PCR, Immunoassay, DNA Staining, Microbial Culture Techniques, Other
By Application
Hospitals, Clinics, Diagnostic Laboratories, Other
By Companies
Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Holding, Savyon Diagnostics, Tecan Group, Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Mycoplasma Diagnostics Devices Market Report Segments:
The global Mycoplasma Diagnostics Devices market is segmented on the basis of:
Types
PCR, Immunoassay, DNA Staining, Microbial Culture Techniques, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Thermo Fisher Scientific
- PromoCell GmbH
- Charles River Laboratories International
- Merck KGaA
- Lonza Group
- Takara Holding
- Savyon Diagnostics
- Tecan Group
- Sartorius Stedim BioOutsource
- American Type Culture Collection (ATCC)
- F Hoffmann-La Roche
Highlights of The Mycoplasma Diagnostics Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR
- Immunoassay
- DNA Staining
- Microbial Culture Techniques
- Other
- By Application:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycoplasma Diagnostics Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycoplasma Diagnostics Devices (MDD) is a company that manufactures and sells diagnostic devices for the detection of Mycoplasma. MDD's products include nucleic acid amplification tests (NATs), polymerase chain reaction (PCRs) and enzyme-linked immunosorbent assays (ELISAs).
Some of the major players in the mycoplasma diagnostics devices market are Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Holding, Savyon Diagnostics, Tecan Group, Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche.
The mycoplasma diagnostics devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mycoplasma Diagnostics Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mycoplasma Diagnostics Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mycoplasma Diagnostics Devices Market - Supply Chain
4.5. Global Mycoplasma Diagnostics Devices Market Forecast
4.5.1. Mycoplasma Diagnostics Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mycoplasma Diagnostics Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mycoplasma Diagnostics Devices Market Absolute $ Opportunity
5. Global Mycoplasma Diagnostics Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
5.3.1. PCR
5.3.2. Immunoassay
5.3.3. DNA Staining
5.3.4. Microbial Culture Techniques
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mycoplasma Diagnostics Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostic Laboratories
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mycoplasma Diagnostics Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mycoplasma Diagnostics Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mycoplasma Diagnostics Devices Demand Share Forecast, 2019-2026
9. North America Mycoplasma Diagnostics Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Diagnostic Laboratories
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
9.7.1. PCR
9.7.2. Immunoassay
9.7.3. DNA Staining
9.7.4. Microbial Culture Techniques
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mycoplasma Diagnostics Devices Demand Share Forecast, 2019-2026
10. Latin America Mycoplasma Diagnostics Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Laboratories
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
10.7.1. PCR
10.7.2. Immunoassay
10.7.3. DNA Staining
10.7.4. Microbial Culture Techniques
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mycoplasma Diagnostics Devices Demand Share Forecast, 2019-2026
11. Europe Mycoplasma Diagnostics Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Laboratories
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
11.7.1. PCR
11.7.2. Immunoassay
11.7.3. DNA Staining
11.7.4. Microbial Culture Techniques
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mycoplasma Diagnostics Devices Demand Share, 2019-2026
12. Asia Pacific Mycoplasma Diagnostics Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Laboratories
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
12.7.1. PCR
12.7.2. Immunoassay
12.7.3. DNA Staining
12.7.4. Microbial Culture Techniques
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mycoplasma Diagnostics Devices Demand Share, 2019-2026
13. Middle East & Africa Mycoplasma Diagnostics Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Laboratories
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mycoplasma Diagnostics Devices Market Size and Volume Forecast by Type
13.7.1. PCR
13.7.2. Immunoassay
13.7.3. DNA Staining
13.7.4. Microbial Culture Techniques
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mycoplasma Diagnostics Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mycoplasma Diagnostics Devices Market: Market Share Analysis
14.2. Mycoplasma Diagnostics Devices Distributors and Customers
14.3. Mycoplasma Diagnostics Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. PromoCell GmbH
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Charles River Laboratories International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck KGaA
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lonza Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Takara Holding
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Savyon Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Tecan Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sartorius Stedim BioOutsource
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. American Type Culture Collection (ATCC)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. F Hoffmann-La Roche
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
